Gilead Sciences, Inc. (NASDAQ:GILD)

CAPS Rating: 5 out of 5

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

GILD News and Commentary

View All GILD News and Commentary

Caps

How do you think GILD will perform against the market?

Add Stock to CAPS Watchlist

All Players

3,628 Outperform
85 Underperform
 

All-Star Players

795 Outperform
16 Underperform
 

Wall Street

29 Outperform
3 Underperform
 

Top GILD Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

glenncv (61.31)
Submitted September 09, 2017

I love company with a health balance sheet. GILD became famous for their HIV drug as they control this space. However, in 2017 and 2021 the company has some patent expiring on their HIV drug. So the company was smart to start diversifying their… More

nhatch3353 (35.79)
Submitted March 23, 2016

Patent problems and trouble with cancer drug trials.

GILD VS S&P 500 (SPY)

Fools bullish on GILD are also bullish on:

Fools bearish on GILD are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about GILD.

Recs

0
Member Avatar Capitalism (58.64) Submitted: 9/25/2017 9:05:56 AM : Outperform Start Price: $83.41 GILD Score: +0.45

DoctorRX pick (Seeking alpha)

Recs

0
Member Avatar KrimmelMoney (46.02) Submitted: 9/14/2017 4:26:12 PM : Outperform Start Price: $82.95 GILD Score: +0.87

Gildead continues to make smart acquisitions of low risk drugs while continuing to develop their own offering. With their massive cash, they are poised to make a lot of money, as long as they continue to be strategic in their acquisitions.

Recs

1
Member Avatar glenncv (61.31) Submitted: 9/9/2017 5:18:32 PM : Outperform Start Price: $82.98 GILD Score: +0.27

I love company with a health balance sheet. GILD became famous for their HIV drug as they control this space. However, in 2017 and 2021 the company has some patent expiring on their HIV drug. So the company was smart to start diversifying their pipeline by adding hepatitis C drugs to maintain their market share. However, they control both market and in order to continue to grow and replace the revenue they will be losing because of the patent expiration they need another area of growth. With the Kite purchase, GILD now has a healthy pipeline to go into the cancer drug area. I suspect they will be buying more companies with all the cash they still have on their balance sheet. The company offers a 2.5% dividend yield as well.

Leaderboard

Find the members with the highest scoring picks in GILD.

Score Leader

BrianMotleyFool

BrianMotleyFool (78.47) Score: +536.73

The Score Leader is the player with the highest score across all their picks in GILD.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
JSergeant 68.69 7/3/2006 Outperform 3Y $13.97 +499.45% +108.24% +391.21 0 Comment
UrineLuck73 < 20 1/29/2007 Outperform NS $14.75 +467.68% +85.93% +381.75 0 Comment
WilliamCrook2003 70.74 1/29/2007 1/25/2012 Outperform 5Y $14.75 +467.68% +85.93% +381.75 1 Comment
predragj 60.13 1/30/2007 Outperform NS $14.94 +460.49% +85.72% +374.77 0 Comment
macattack90009 < 20 10/4/2006 Outperform 3M $14.63 +472.45% +98.82% +373.63 0 Comment
kaliking 69.20 10/4/2006 Outperform 3W $14.63 +472.45% +98.82% +373.63 0 Comment
axk38 < 20 10/4/2006 Outperform 1Y $14.63 +472.45% +98.82% +373.63 0 Comment
murakh39 < 20 10/4/2006 Outperform 3M $14.63 +472.45% +98.82% +373.63 0 Comment
mxdfool < 20 12/15/2006 Outperform 5Y $15.01 +457.94% +85.08% +372.85 0 Comment
betsypurcell < 20 1/24/2007 Outperform NS $15.03 +457.16% +84.92% +372.24 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 84.65 2/22/2017 Underperform 3W $67.34 +24.39% +5.42% -18.97 0 Comment
TrackStandpoint 40.62 2/3/2016 Outperform 5Y $81.20 +3.15% +30.13% -26.98 0 Comment
TrackJGreenblatt 69.17 8/18/2015 Outperform 1Y $110.53 -24.22% +18.46% -42.68 1 Comment
TrackJimCramer 84.65 2/23/2015 Outperform 3W $100.96 -31.82% +11.87% -43.69 2/22/2017 @ $68.83 0 Comment
TrackJimCramer 84.65 12/22/2014 Underperform 3W $92.90 +12.50% +1.80% -10.69 2/23/2015 @ $104.51 0 Comment
TrackStandpoint 40.62 3/6/2014 Underperform 5Y $81.98 -6.90% -1.08% +5.82 3/17/2014 @ $76.33 0 Comment
tracknomura 97.80 1/8/2014 Outperform NS $69.15 +21.13% +35.78% -14.65 0 Comment
TrackPiperJaff 86.74 11/27/2013 Outperform NS $70.39 +19.00% +37.71% -18.72 0 Comment
TrackArgus 91.18 6/14/2013 Outperform NS $49.04 +70.80% +51.85% +18.95 0 Comment
TrackCreditSuiss 91.57 3/26/2013 Underperform NS $42.67 +96.30% +60.09% -36.21 0 Comment
TrackZacks < 20 10/24/2012 Outperform 3M $34.17 +5.28% -1.76% +7.04 11/12/2012 @ $35.98 1 Comment
TrackLazardCapit 81.07 10/8/2012 Outperform NS $32.94 +154.32% +71.07% +83.24 0 Comment
TrackBernstein 92.71 10/1/2012 Outperform NS $32.20 +160.14% +72.35% +87.79 0 Comment
TrackBarclaysCap 93.37 8/3/2012 Outperform NS $27.35 +206.25% +79.76% +126.49 0 Comment
TrackJimCramer 84.65 7/27/2012 Outperform 3W $27.75 +234.77% +49.60% +185.17 12/22/2014 @ $92.90 0 Comment
TrackZacks < 20 2/21/2012 Underperform 3M $22.35 +16.72% +2.87% -13.84 4/27/2012 @ $26.08 1 Comment
TrackBarclaysCap 93.37 2/10/2012 Outperform NS $26.77 -15.15% +1.91% -17.06 2/21/2012 @ $22.71 0 Comment
TrackNeedham 91.27 2/3/2012 Outperform NS $25.24 +231.88% +85.88% +146.00 0 Comment
TrackJimCramer 84.65 11/29/2011 Underperform 3W $19.64 +41.33% +15.52% -25.81 7/27/2012 @ $27.75 0 Comment
TrackUltraLong < 20 11/23/2011 Underperform NS $19.76 +94.61% +24.35% -70.25 1/7/2013 @ $38.45 1 Comment
TrackGoldmanSach 77.29 10/21/2011 Outperform 5Y $19.56 +328.26% +102.36% +225.90 1 Comment
tracksummerstree 91.27 8/16/2011 Outperform NS $18.64 +2.36% -0.43% +2.79 11/22/2011 @ $19.07 0 Comment
TrackBreanMurray 77.86 8/9/2011 Outperform NS $17.61 +375.60% +118.36% +257.24 0 Comment
TrackJimCramer 84.65 3/25/2011 Outperform 3W $21.04 -6.68% -8.57% +1.89 11/30/2011 @ $19.64 0 Comment
TrackRBCCapMkts 90.07 11/1/2010 Outperform NS $18.86 +344.15% +109.19% +234.96 0 Comment
TrackZacks < 20 10/20/2010 Outperform 3M $19.20 -4.77% +6.38% -11.15 12/21/2010 @ $18.28 1 Comment
TrackMuhlenkamp 45.65 9/30/2010 Outperform NS $16.83 +397.77% +120.35% +277.43 0 Comment
TrackStandpoint 40.62 7/13/2010 Outperform NS $17.47 +17.60% +11.47% +6.13 10/19/2011 @ $20.55 0 Comment
TrackJimCramer 84.65 5/26/2010 Underperform 3W $17.41 +20.85% +22.52% +1.67 3/25/2011 @ $21.04 0 Comment
TrackPiperJaff 86.74 3/12/2010 Outperform NS $23.88 -12.08% +4.49% -16.57 4/21/2010 @ $20.99 0 Comment
TrackZacks < 20 3/1/2010 Outperform 3M $23.76 -2.44% +7.10% -9.54 4/13/2010 @ $23.18 1 Comment
TrackMorganJos 78.06 2/22/2010 Underperform NS $24.28 -25.52% -5.68% +19.84 5/25/2010 @ $18.08 0 Comment
TrackRothCapital 71.04 2/19/2010 Outperform NS $24.55 -16.21% +22.40% -38.61 5/3/2011 @ $20.57 0 Comment
TrackWedbush 86.67 10/21/2009 Underperform NS $21.39 +291.56% +128.43% -163.13 0 Comment
TrackMorganJos 78.06 4/22/2009 Outperform NS $23.12 +5.02% +31.77% -26.75 2/22/2010 @ $24.28 0 Comment
trackthinkequity 90.57 4/14/2009 Outperform NS $22.33 +275.15% +195.98% +79.16 0 Comment
TrackWedbush 86.67 3/13/2009 Outperform NS $22.30 +1.53% +44.09% -42.56 10/21/2009 @ $22.64 0 Comment
TrackStanfordRes < 20 12/23/2008 Outperform NS $25.07 -7.82% +57.74% -65.56 4/17/2012 @ $23.11 0 Comment
trackmerriman 74.07 12/15/2008 Outperform NS $21.24 +294.34% +187.06% +107.28 0 Comment
TrackNeedham 91.27 11/12/2008 Outperform NS $21.95 -2.89% +50.63% -53.52 3/31/2011 @ $21.32 0 Comment
TrackArgus 91.18 10/27/2008 Outperform NS $21.18 -9.28% +36.58% -45.86 11/23/2011 @ $19.21 0 Comment
TrackBofASec 96.05 10/24/2008 Outperform NS $20.23 +314.05% +203.53% +110.53 0 Comment
TrackZacks < 20 10/20/2008 Outperform 3M $23.25 +2.88% -4.74% +7.62 7/17/2009 @ $23.92 1 Comment
TrackBMOCapital < 20 10/17/2008 Outperform NS $20.28 +313.09% +172.47% +140.62 0 Comment
TrackRWBaird 90.03 9/12/2008 Outperform NS $23.35 +258.68% +106.73% +151.94 0 Comment
TrackLadenburg < 20 7/18/2008 Outperform NS $23.54 +255.87% +104.48% +151.38 0 Comment
TrackDeutscheSec 89.99 6/19/2008 Outperform NS $25.12 +233.38% +92.58% +140.80 0 Comment
TrackPacificGrow < 20 5/21/2008 Outperform NS $26.29 -12.10% -1.15% -10.95 4/17/2012 @ $23.11 0 Comment
TrackOppenheimer 70.74 4/17/2008 Outperform NS $24.09 +247.63% +89.67% +157.96 0 Comment
TrackJimCramer 84.65 4/2/2008 Outperform 3W $25.95 -32.91% -21.65% -11.26 5/26/2010 @ $17.41 0 Comment
TrackDodgeCox 97.11 3/31/2008 Outperform NS $24.35 +243.99% +95.73% +148.26 1 Comment
TrackJimCramer 84.65 3/13/2008 Underperform 3W $24.25 +7.03% +3.90% -3.13 4/3/2008 @ $25.95 0 Comment
TrackWellsFargo 91.42 1/31/2008 Outperform NS $21.21 +294.96% +94.59% +200.37 0 Comment
TrackFBRCapitalM 89.90 1/24/2008 Outperform NS $22.96 +15.31% -5.04% +20.35 6/30/2008 @ $26.48 0 Comment
TrackCreditSuiss 91.57 1/7/2008 Outperform NS $23.42 +92.53% +9.30% +83.23 3/25/2013 @ $45.08 0 Comment
TrackEdwardOwens 99.71 9/30/2007 Outperform NS $19.31 +333.71% +71.04% +262.68 7 Comments
TrackBMOCapital < 20 9/28/2007 Outperform NS $20.44 +25.73% -17.80% +43.53 7/18/2008 @ $25.70 0 Comment
TrackJimJubak < 20 9/25/2007 Outperform 1Y $20.36 +60.49% -8.55% +69.04 11/9/2012 @ $32.68 0 Comment
TrackZacks < 20 6/11/2007 Outperform 3M $19.81 +10.12% -9.23% +19.36 2/25/2008 @ $21.81 1 Comment
TrackJimCramer 84.65 5/18/2007 Outperform 3W $20.76 +16.82% -13.74% +30.56 3/14/2008 @ $24.25 0 Comment
TrackBWS 97.12 4/19/2007 Outperform NS $20.45 +14.19% -11.57% +25.76 1/18/2012 @ $23.36 0 Comment
TrackLeerinkSwan 98.40 4/19/2007 Outperform NS $18.66 +348.87% +79.63% +269.24 0 Comment
TrackJimCramer 84.65 4/5/2007 Underperform 3W $19.58 +6.00% +5.81% -0.19 5/19/2007 @ $20.76 0 Comment
TrackUBS 93.37 2/21/2007 Outperform NS $17.25 +385.64% +81.56% +304.08 0 Comment
TrackJefferies 85.69 2/21/2007 Outperform NS $18.25 +40.82% -13.96% +54.78 7/18/2008 @ $25.70 0 Comment
TrackDeutscheSec 89.99 2/2/2007 Outperform NS $17.75 +15.04% +5.60% +9.45 6/6/2007 @ $20.42 0 Comment
TrackPZK < 20 2/2/2007 Outperform NS $17.75 +30.17% -4.60% +34.77 4/17/2012 @ $23.11 0 Comment
TrackStifel 94.53 2/1/2007 Outperform NS $16.52 +407.17% +83.41% +323.76 0 Comment
TrackJMP 84.38 2/1/2007 Outperform NS $16.52 +407.17% +83.41% +323.76 0 Comment
TrackBofASec 96.05 2/1/2007 Outperform NS $17.46 +47.05% -9.91% +56.96 9/2/2008 @ $25.68 0 Comment
TrackCarisandCo 92.80 12/21/2006 Outperform NS $16.25 +49.25% -7.46% +56.71 3/13/2008 @ $24.25 0 Comment
TrackBroadpointAmTech < 20 12/19/2006 Outperform NS $15.93 +45.04% -2.37% +47.42 4/17/2012 @ $23.11 0 Comment
TrackRodmanRen < 20 12/4/2006 Outperform NS $15.55 +438.77% +88.50% +350.27 0 Comment
TrackLazardCapit 81.07 11/22/2006 Outperform NS $16.90 +70.53% -0.06% +70.59 8/7/2012 @ $28.82 0 Comment
TrackLehmanBros < 20 10/19/2006 Outperform NS $16.99 +55.41% -5.17% +60.58 8/28/2008 @ $26.41 0 Comment
TrackCreditSuiss 91.57 9/28/2006 Outperform NS $16.86 +21.10% +14.18% +6.91 6/6/2007 @ $20.42 0 Comment
TrackRBCCapMkts 90.07 9/27/2006 Outperform NS $16.72 -2.68% -18.97% +16.29 7/21/2010 @ $16.28 0 Comment
TrackMontgomery < 20 8/16/2006 Outperform NS $15.65 +9.86% -3.13% +12.99 10/1/2006 @ $17.19 0 Comment
TrackJimCramer 84.65 3/8/2006 Outperform 3W $15.20 +28.86% +12.72% +16.13 4/5/2007 @ $19.58 0 Comment

Featured Broker Partners